Dr. Bradwejn is Founding Dean (Canada), Ottawa-Shanghai Joint School of Medicine, Shanghai and Visiting Professor at the Shanghai Jiao Tong University School of Medicine. He is also Ex-Dean of the Faculty of Medicine at University of Ottawa. Prior to this appointment, he served as Chair of the Department of psychiatry of the University of Ottawa and as Psychiatrist-in-Chief at the Royal Ottawa Hospital, from 1998 to 2006 and as Head of Psychiatry of the Ottawa Hospital from 1999 to 2006. Before holding positions in Ottawa, he held positions at McGill University as Associate Professor of Psychiatry and at the University of Toronto as Professor of Psychiatry.Dr. Bradwejn trained in medicine at the University of Sherbrooke and in psychiatry at McGill University. He completed a research fellowship in psychopharmacology at McGill University and in neuropsychopharmacology at the University of Montreal. Dr. Bradwejn has also completed the Wharton Certificate of Professional Development at the Wharton School, University of Pennsylvania and was a member of the Wharton Fellows Program.Dr. Bradwejn has been actively involved in psychiatric and mental health research. His main research interest has been in the field of anxiety disorders. He was the first to report that administration of cholecystokinin-tetrapeptide (CCK-4) induces panic attacks in patients suffering from panic disorder and has gained an international reputation for his work with this neuropeptide. He has recently expanded his research interests to integration of biological and psychological approaches in the treatment of anxiety disorders and to approaches used by Complementary Medicines.Dr. Bradwejn has published over 180 articles and book chapters, has made more than 400 scientific and educational conferences and over 350 educational media interventions.Specialties: Psychiatry, psychopharmacology, psychotherapy, medical education and research, leadership, coaching.